Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
Rybelsus is approved to improve blood sugar in adults with type 2 diabetes and is taken orally once daily
Allison L
, , ,
US$ 25.65
US$ 21.48
US$ 23.82
US$ 27.93
US$ 27.93
US$ 29.47
